XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 160 filers reported holding XENON PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $167,384,000 | -11.3% | 4,900,000 | 0.0% | 2.61% | +2.0% |
| Q2 2023 | $188,650,000 | +7.6% | 4,900,000 | 0.0% | 2.56% | -1.6% |
| Q1 2023 | $175,371,000 | -9.2% | 4,900,000 | 0.0% | 2.60% | -9.9% |
| Q4 2022 | $193,207,000 | +9.2% | 4,900,000 | 0.0% | 2.89% | -11.7% |
| Q3 2022 | $176,890,000 | +18.7% | 4,900,000 | 0.0% | 3.27% | +11.0% |
| Q2 2022 | $149,058,000 | -2.2% | 4,900,000 | -1.7% | 2.94% | +5.9% |
| Q1 2022 | $152,391,000 | -2.1% | 4,985,000 | 0.0% | 2.78% | +5.0% |
| Q4 2021 | $155,731,000 | +179.2% | 4,985,000 | +36.6% | 2.65% | +202.5% |
| Q3 2021 | $55,772,000 | -17.9% | 3,650,000 | 0.0% | 0.88% | -25.9% |
| Q2 2021 | $67,963,000 | +4.0% | 3,650,000 | 0.0% | 1.18% | +4.8% |
| Q1 2021 | $65,335,000 | +51.7% | 3,650,000 | +30.4% | 1.13% | +52.0% |
| Q4 2020 | $43,064,000 | +38.9% | 2,800,000 | 0.0% | 0.74% | +68.6% |
| Q3 2020 | $30,996,000 | -11.7% | 2,800,000 | 0.0% | 0.44% | -36.6% |
| Q2 2020 | $35,112,000 | +11.7% | 2,800,000 | +1.0% | 0.69% | -34.6% |
| Q1 2020 | $31,434,000 | -0.1% | 2,772,000 | +15.5% | 1.06% | +14.8% |
| Q4 2019 | $31,464,000 | +45.5% | 2,400,000 | 0.0% | 0.92% | +2.4% |
| Q3 2019 | $21,624,000 | -8.6% | 2,400,000 | 0.0% | 0.90% | +10.3% |
| Q2 2019 | $23,664,000 | -3.0% | 2,400,000 | 0.0% | 0.82% | -22.4% |
| Q1 2019 | $24,384,000 | +61.0% | 2,400,000 | 0.0% | 1.05% | +16.5% |
| Q4 2018 | $15,144,000 | -51.5% | 2,400,000 | +1.4% | 0.90% | -36.9% |
| Q3 2018 | $31,247,000 | +182.5% | 2,367,218 | +96.9% | 1.44% | +236.9% |
| Q2 2018 | $11,059,000 | – | 1,202,118 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 266,961 | $9,119,388 | 10.70% |
| COMMODORE CAPITAL LP | 1,845,000 | $63,025,200 | 7.37% |
| TLS Advisors LLC | 32,956 | $1,126 | 4.56% |
| Altium Capital Management LP | 228,000 | $7,788,480 | 4.06% |
| Paradigm Biocapital Advisors LP | 1,491,835 | $50,961,084 | 3.46% |
| GREAT POINT PARTNERS LLC | 500,001 | $17,080,034 | 3.11% |
| DAFNA Capital Management LLC | 280,538 | $9,583,178 | 2.98% |
| Nan Fung Group Holdings Ltd | 106,680 | $3,644,189 | 2.95% |
| Affinity Asset Advisors, LLC | 300,438 | $10,262,962 | 2.89% |
| Avoro Capital Advisors LLC | 4,900,000 | $167,384,000 | 2.61% |